Viewing Study NCT01958918


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2026-02-25 @ 2:36 AM
Study NCT ID: NCT01958918
Status: COMPLETED
Last Update Posted: 2019-03-21
First Post: 2013-10-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None wet age-related macular degeneration (AMD) View
None ranibizumab View
None aflibercept View
None Best Corrected Visual Acuity (BCVA) View
None Spectral Domain Optical Coherence Tomography (SD-OCT) View